KRTL Holding Group, Inc. manufactures and distributes water. The company is headquartered in Lakewood, Colorado. The company went IPO on 2001-06-21. The firm operates through its subsidiaries, including KRTL Biotech, Inc., KRTL International Corp and Neurogen Brain Balancing, LLC (Neurogen). KRTL Biotech, Inc. is a pharmaceutical company focused on the commercialization of APIs and licensing agreements within the pharmaceutical and nutraceutical sectors. KRTL Biotech, Inc. focuses on biotechnology, particularly in securing and developing global partnerships for the sourcing and distribution of critical APIs and wellness-focused compounds. KRTL International Corp focuses on bridging global markets through international consulting, trade and distribution of advanced bio and agri-technologies and services. Neurogen is a neurotechnology company focused on advanced brain balancing therapies and personalized cognitive optimization systems.
최신 재무제표(Form-10K)에 따르면, Close Brothers Group plc의 총 자산은 $0이며, 순손실입니다.
KRTL의 주요 재무 비율은 무엇인가요?
Close Brothers Group plc의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
KRTL Holding Group Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Close Brothers Group plc 주요 수익원은 Commercial이며, 최신 수익 발표에서 수익은 329,600,000입니다. 지역별로는 United Kingdom이 Close Brothers Group plc의 주요 시장이며, 수익은 944,200,000입니다.
KRTL Holding Group Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Close Brothers Group plc의 순손실은 $0입니다.